-- 美國全國住宅建築商協會（NAHB）4月公佈的月度房屋市場指數從3月修正後的38降至34，低於彭博社截至美國東部時間上午7:40匯總的調查結果所預測的37。 該指數低於一年前的40，也是自2025年9月以來的最低水準。 單戶住宅銷售量、六個月展望、購屋者流量均下滑。 NAHB主席比爾歐文斯表示：「由於購屋者面臨持續高企的利率和日益增長的經濟不確定性，建築商信心在春季有所回落。年初市場曾寄希望於住房市場增長勢頭強勁，但伊朗戰爭、能源成本上漲以及消費者信心下降等風險因素導致市場放緩。」 NAHB首席經濟學家羅伯特·迪茨指出，油價上漲推高了建築材料成本。 迪茨表示：「能源成本約佔住宅建築材料投入和服務成本的4%。」由於近期經濟風險較高，70%的建築商表示，由於材料成本的不確定性，房屋定價面臨挑戰。
Related Articles
Asia
National Australia Bank Shares Down After Resolution of Union Court Proceedings
National Australia Bank (ASX:NAB) shares were down about 1% in recent Monday trade following a Friday settlement with the Finance Sector Union of Australia to resolve court proceedings related to excessive additional working hours for employees.The settlement, reached on a without-admissions basis through mediation, includes the establishment of a health, safety, and well-being framework to mitigate the risks linked to working additional hours, and calls for greater oversight of such risks.The union and the bank said in a joint statement that they are "committed to continuing to work together to ensure fair and sustainable outcomes for all [National Australia Bank] employees."
$ASX:NAB
Asia
Clinuvel Pharmaceuticals Says FDA Removes Post-Authorization Requirement for Implant
Clinuvel Pharmaceuticals (ASX:CUV) said the US Food and Drug Administration (FDA) removed a requirement for a post-authorization phase one study on cardiac repolarization in relation to its Scenesse implant upon reviewing its long-term safety profile, according to a Monday filing with the Australian bourse.Scenesse is used to treat patients with erythropoietic protoporphyria, a disease that causes intolerance to light.The FDA concluded that the study was no longer needed since it would not yield valuable safety information, the filing said.
$ASX:CUV
Asia
XRF Scientific Completes Acquisition of Combustion Gas Analysis Business
XRF Scientific (ASX:XRF) has completed the acquisition of the combustion gas analysis business from Bruker AXS, according to a Monday Australian bourse filing.The company entered a binding agreement to acquire the combustion gas analysis business for $4 million upfront plus a potential $1 million earnout based on 7% of net revenue over three years, an earlier filing showed.
$ASX:XRF